Raymond James & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.12B | Buy |
|
|||||
|
2024
Q2 | $1.21B | Sell |
|
|||||
|
2024
Q1 | $1.29B | Buy |
|
|||||
|
2023
Q4 | $1.05B | Buy |
|
|||||
|
2023
Q3 | $969M | Buy |
|
|||||
|
2023
Q2 | $1.08B | Sell |
|
|||||
|
2023
Q1 | $1.01B | Sell |
|
|||||
|
2022
Q4 | $1.07B | Buy |
|
|||||
|
2022
Q3 | $778M | Buy |
|
|||||
|
2022
Q2 | $799M | Sell |
|
|||||
|
2022
Q1 | $730M | Buy |
|
|||||
|
2021
Q4 | $650M | Sell |
|
|||||
|
2021
Q3 | $653M | Buy |
|
|||||
|
2021
Q2 | $652M | Buy |
|
|||||
|
2021
Q1 | $585M | Buy |
|
|||||
|
2020
Q4 | $618M | Buy |
|
|||||
|
2020
Q3 | $604M | Buy |
|
|||||
|
2020
Q2 | $556M | Buy |
|
|||||
|
2020
Q1 | $519M | Buy |
|
|||||
|
2019
Q4 | $569M | Buy |
|
|||||
|
2019
Q3 | $503M | Buy |
|
|||||
|
2019
Q2 | $485M | Buy |
|
|||||
|
2019
Q1 | $464M | Buy |
|
|||||
|
2018
Q4 | $417M | Buy |
|
|||||
|
2018
Q3 | $377M | Buy |
|
|||||
|
2018
Q2 | $317M | Sell |
|
|||||
|
2018
Q1 | $312M | Buy |
|
|||||
|
2017
Q4 | $300M | Buy |
|
|||||
|
2017
Q3 | $338M | Buy |
|
|||||
|
2017
Q2 | $334M | Buy |
|
|||||
|
2017
Q1 | $331M | Buy |
|
|||||
|
2016
Q4 | $292M | Buy |
|
|||||
|
2016
Q3 | $282M | Buy |
|
|||||
|
2016
Q2 | $233M | Buy |
|
|||||
|
2016
Q1 | $193M | Buy |
|
|||||
|
2015
Q4 | $184M | Buy |
|
|||||
|
2015
Q3 | $170M | Buy |
|
|||||
|
2015
Q2 | $188M | Buy |
|
|||||
|
2015
Q1 | $185M | Buy |
|
|||||
|
2014
Q4 | $159M | Buy |
|
|||||
|
2014
Q3 | $134M | Buy |
|
|||||
|
2014
Q2 | $103M | Buy |
|
|||||
|
2014
Q1 | $99.9M | Sell |
|
|||||
|
2013
Q4 | $90.1M | Buy |
|
|||||
|
2013
Q3 | $81M | Buy |
|
|||||
|
2013
Q2 | $74.5M | Buy |
|